Key result
Elevated baseline plasma DHEAS was not associated with a decreased risk of myocardial infarction in men comparing extreme quintiles.
Case-Control (n=338)
Answers are grounded in this paper and cite their sources.
High levels of dehydroepiandrosterone sulfate (DHEAS) have been associated with decreased risks of cardiovascular disease. The authors analyzed DHEAS in plasma collected at baseline among 169 participants in the Physicians' Health Study who subsequently had a myocardial infarction and 169 matched controls. The mean prediagnostic plasma DHEAS levels between cases (p = 0.33) (mean, 3.54 mumol/liter; standard deviation, 2.30) and controls (mean, 3.61 mumol/liter; standard deviation, 2.16) did not differ significantly. The relative risk was 1.04 (95 percent confidence interval 0.42-2.60) comparing extreme quintiles after adjustment for several coronary risk factors. In conclusion, these findings do not support the hypothesis that elevated plasma DHEAS is associated with a decreased risk of coronary disease in men, but a small to moderate association cannot be excluded.
No takes yet. Share an insight, caveat, or question.
Newcomer et al. (1994) conducted a case-control in Myocardial Infarction (n=338). Baseline plasma dehydroepiandrosterone sulfate (DHEAS) levels vs. Matched controls / lowest quintile of DHEAS was evaluated on Myocardial infarction (RR 1.04, 95% CI 0.42-2.60, p=0.33). Elevated baseline plasma DHEAS was not associated with a decreased risk of myocardial infarction in men comparing extreme quintiles.
Synapse has enriched 10 related papers. Consider them for comparative context: